This is the first demonstration that virulence of human pathogenic bacteria can be mitigated by molecules secreted in probiotic milk products, such as yogurt or kefir, said BGU Prof. Jelinek. Our research illuminates the mechanism by which milk fermented probiotics can protect against pathogenic infections and aid the immune system. We look forward to administering these drug candidates to patients who are experiencing a cytokine storm due to COVID-19 infection, or people suffering from acute inflammatory bowel pathologies, such as Crohn s disease.
Share this article
Share this article
BEER-SHEVA, Israel, April 8, 2021 /PRNewswire/ Researchers at Ben-Gurion University of the Negev (BGU) have identified novel drug candidates based on molecules isolated from probiotic yogurt for combating pathogenic bacteria and for treating various inflammatory conditions, including inflammatory bowel disease (IBD) and COVID-19 related cytokine storms. The research, led by Ms. Orit Malka, a PhD student in the laboratory of Prof. Raz Jelinek, the Vice President and Dean for Research & Development at BGU, was published in
Microbiome, a leading peer-reviewed publication.
Prof. Raz Jelinek and Ms. Orit Malka with their unique probiotic yogurt at Ben-Gurion University laboratory (Credit: Dani Machlis) (PRNewsfoto/BGN Technologies)
Share this article
Share this article
BEER-SHEVA, Israel, April 8, 2021 /PRNewswire/ Researchers at Ben-Gurion University of the Negev (BGU) have identified novel drug candidates based on molecules isolated from probiotic yogurt for combating pathogenic bacteria and for treating various inflammatory conditions, including inflammatory bowel disease (IBD) and COVID-19 related cytokine storms. The research, led by Ms. Orit Malka, a PhD student in the laboratory of Prof. Raz Jelinek, the Vice President and Dean for Research & Development at BGU, was published in
Microbiome, a leading peer-reviewed publication.
Prof. Raz Jelinek and Ms. Orit Malka with their unique probiotic yogurt at Ben-Gurion University laboratory (Credit: Dani Machlis) (PRNewsfoto/BGN Technologies)
Researchers from Ben-Gurion University of the Negev recently developed a rapid and cost-effective test to identify COVID-19’s British and South African variants within hours instead of days, enabling effective response
Researchers develop cheap, rapid test for Covid variants
Quick testing of coronavirus strains can enable effective response and containment measures.
March 17, 2021, 1:12 pm
Coronavirus testing near the northern Israeli town of Katzrin, Golan Heights, February 21, 2021. Photo by Michael Giladi/Flash 90
Researchers from Ben-Gurion University of the Negev recently developed a rapid and cost-effective test to identify Covid-19’s British and South African variants within hours instead of days, enabling effective response and containment measures.
Standard coronavirus variants testing involves sequencing the entire virus genome, a process that is expensive and time-consuming. The new test is based on the gene deletion that differentiates the South African or British strains of the virus from the original SARS-CoV-2.